Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,749.00
Bid: 1,749.00
Ask: 1,749.50
Change: -26.00 (-1.46%)
Spread: 0.50 (0.029%)
Open: 1,770.00
High: 1,770.00
Low: 1,746.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK investigator says Chinese officials mistreated him to get GSK confession

Thu, 18th Jun 2015 10:30

LONDON/BEIJING, June 18 (Reuters) - A British corporateinvestigator freed from a Chinese jail last week has accusedofficials there of deliberately withholding medical treatment totry to force him to confess to a role in a scandal involvingdrugmaker GlaxoSmithKline Plc (GSK).

Peter Humphrey and his American wife Yu Yingzeng returned toBritain on Wednesday evening after being sentenced in August forillegally obtaining private records of Chinese citizens andselling the information to clients, including GSK.

Their case unfolded alongside a Chinese investigation of GSKthat led to a $489 million fine and has been held up as anexample of the potential risks faced by foreigners gatheringinformation in China.

"We arrive here with a heavy toll on our health," Humphreysaid in comments emailed to Reuters via a family friend. "I havea prostate tumour and Ying has kidney disease.

Humphrey, who has disputed allegations of wrongdoing, saidduring his time in jail, prison officers deliberately obstructedhis requests for the appropriate medical attention.

"Every week in captivity I raised requests for the next stepin the medical process," he said. "I was always refused on thegrounds that I had not signed an admission of crime.

"Neither I nor Ying have ever admitted any guilt as charged.We were not guilty of the offence with which we were charged andconvicted but my health was held hostage to signing such aconfession."

Chinese Foreign Ministry spokesman Lu Kang said thatHumphrey's allegations about mistreatment were "not true".

"The relevant Chinese authorities acted in accordance withthe law and guaranteed his rights," Lu told reporters at a dailynews briefing.

Asked about Humphrey's claims of a forced confession, Lusaid, "I am astonished about this. It seems that his stance wasdifferent before and after."

Humphrey and Yu, who ran risk consultancy ChinaWhys, hadbeen asked by GSK to compile a report into the origins of a sexvideo involving the drug company's former China head, MarkReilly, which had been sent to senior executives at GSK alongwith anonymous emails alleging corruption.

At the time, a GSK spokesman confirmed the video existed butdid not comment on how it related to the alleged briberyscandal. He also said GSK, Britain's largest pharmaceuticalfirm, had hired ChinaWhys to investigate the video. (Reporting by Kate Holton in London and Ben Blanchard and JohnRuwitch in Beijing; Editing by Louise Ireland and Andrew Osborn)

More News
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.